
PCI Biotech is a biopharmaceutical company focusing on developing and commercialising new technologies and novel therapies through its photochemical technology platform originating from world-leading research at the Oslo University Hospital. We are a small team, located at Oslo Cancer Cluster Innovation Park in Oslo, Norway. The company is listed on the Oslo Stock Exchange under the ticker PCIB. The technology platform is under development in two different areas.(1) Photochemical lysis (PCL), for increasing yield and reducing impurities in gene therapy (viral vector) manufacturing.(2)…
Annual Revenue$1M to $5M
Estimated OwnershipPublicBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.